*Sponsored By TD Media. Please see disclosures below. |
|
|---|
|
Progress Made In "CVKD" Supply Chain |
| | | | | Hey Folks, Cadrenal Therapeutics (CVKD) recently announced strong progress on the manufacturing side of its lead pharma candidate, Tecarfarin. The company finished transferring and producing the pharmaceutical's active ingredient earlier this year at a U.S. facility, and the next step—making the final product—is now underway. Tecarfarin is being developed as a new type of blood thinner for patients who need long-term treatment but have limited safe options today. Cadrenal's CEO said this is an important step that supports the company's plan to move forward with clinical trials. Tecarfarin has already received special FDA designations to help speed up development, including for use in patients with heart pumps and those with kidney disease and atrial fibrillation. Anyways...
That's all for now!
Until Next Time, -Damian | P.S. Want our text alerts? Text "ZIPTRADER" to 1-(855)-228-1598 to sign up!
(standard carrier data/text rates apply) |
|
|
|---|
|
*Sponsored By TD Media. Please see disclosures below. |
|
|---|
|
| | 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA |
| You've received it because you've subscribed to our newsletter or are a member of ZipTraderU. |
| This email was sent to reunisoft.cryptonews@blogger.com |
| *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated fifteen thousand USD by ACH Bank Transfer by TD Media LLC, who received funds from Relqo Media LLC, to distribute media via email and SMS for Cadrenal Therapeutics, Inc. (CVKD) from June 29, 2025 to June 30, 2025. ZipTrader has been compensated twenty-five thousand USD by ACH Bank Transfer by TD Media LLC dba Lifewater Media to distribute media via YouTube for Cadrenal Therapeutics, Inc. (CVKD) on September 4, 2023. The reader should assume that paying parties, clients of paying parties, and third parties may own shares and may sell shares during or after this campaign, which could negatively impact the stock price. ZipTrader may receive additional campaigns in the future by TD Media LLC to distribute media for Cadrenal Therapeutics, Inc. (CVKD). As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in Cadrenal Therapeutics, Inc. (CVKD). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Cadrenal Therapeutics, Inc. (CVKD), increased trading volume, and possibly an increased share price of Cadrenal Therapeutics, Inc. (CVKD), which may or may not be temporary and decrease once the marketing arrangement has ended. |
| BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service.See Our Advertisement/Sponsored Stock Disclaimer. |
| | |
|
|
|---|
|
|
|
No comments:
Post a Comment